Recruiting Coordinator
About the job
- An associate degree or equivalent is required.
- At least 2 years of recruiting coordinator, scheduling, or equivalent experience is required.
- Attention to detail, organizational skills, and the ability to follow instructions are required.
- Strong written and verbal communication skills are required.
- The ability to prioritize and manage multiple tasks simultaneously is required.
- The candidate must be able to keep data confidential.
- Experience with Outlook is required.
- Manage complex scheduling with stakeholders at all levels, including the management team, and coordinate candidate engagement throughout the recruitment lifecycle, including scheduling, travel, and food arrangements.
- Provide timely follow-up to deliver a positive candidate experience and ensure interviews are well organized and confirmed.
- Perform administrative duties supporting the recruiting function, including documentation and tracking and maintaining applicant records.
- Organize and track recruiting-related correspondence, including applications, forms, and offer letters, ensuring accuracy and data compliance through online tools such as Greenhouse.
- Follow standard operating procedures to maintain compliance with applicable federal, state, and local employment and benefits laws and regulations.
- Perform additional responsibilities as assigned.
- Experience with Greenhouse, Paylocity, and a Jira ticketing system is desired.
- The ability to thrive in a fast-paced, agile environment is desired.
About the company
PsiQuantum builds utility-scale quantum computers that use photons as qubits and a semiconductor-compatible Omega chipset. The Omega platform combines single-photon sources, superconducting detectors, and optical switches to enable scalable chip-to-chip interconnects and high-fidelity quantum operations. It differentiates itself by using manufacturable semiconductor processes, pursuing large-scale integration, and exploring fault-tolerant approaches like fusion-based quantum computation (FBQC) with collaborations with government and research institutions. The goal is to deliver a scalable, fault-tolerant quantum computer capable of solving real-world problems in chemistry, materials science, optimization, and cryptography beyond what classical computers can handle.
Company Size
501-1,000
Company Stage
Growth Equity (Non-Venture Capital)
Total Funding
$2.9B
Headquarters
Palo Alto, California
Founded
2015
Get referred to PsiQuantum
See people who can refer or advise you
Simplify's Take
What believers are saying
- September 8, 2026 Commerce funding added $100 million for optical switches and detectors.
- July 2026 DARPA QBI contract added $125 million and commercial credibility.
- September 2026 Moreton Bay construction and Linde's cryogenic plant prove execution.
What critics are saying
- A 2028 Quantum Genesis deadline leaves PsiQuantum exposed if hardware slips past milestones.
- Illinois Quantum and Microelectronics Park critics target water, power, and contamination costs in Chicago.
- If photonic integration fails, PsiQuantum becomes a billion-dollar science project with no product.
What makes PsiQuantum unique
- PsiQuantum's silicon-photonics stack uses semiconductor fabs, unlike trapped-ion rivals.
- Victor Peng and Jeremy O'Brien coordinate Brisbane and Chicago utility-scale buildouts.
- Construct, launched May 2026, turns fault-tolerant algorithm design into an open platform.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Company Equity
Stock Options
Growth & Insights and Company News
6 month growth
0%1 year growth
0%2 year growth
1%The Department of War announced about $350 million in quantum-computing initiatives on October 8, to support national-security uses and the US quantum industry. About $200 million in new funding goes to Atom Computing, Diraq, IBM, and IonQ, which advanced to Stage C of the Defense Advanced Research Projects Agency's (DARPA) Quantum Benchmarking Initiative. Stage C will test whether their proposed systems can be built and run as planned. The Office of Strategic Capital also announced a conditional loan commitment of about $150 million for PsiQuantum's US manufacturing and prototyping work. It is not confirmed funding. "Stage C is where we begin moving from plans to proof," said Micah Stoutimore, the initiative's managing director. The programme is testing whether a quantum approach can reach utility-scale operation by 2033.
PsiQuantum receives conditional $150M loan commitment to advance US quantum computing. October 8, 2026 Press play to listen to this content PALO ALTO, Calif., Oct. 8, 2026 - PsiQuantum announced today that the company has received a conditional commitment for a loan of up to $150 million from the U.S. Department of Defense's Office of Strategic Capital (OSC), which would expand the company's advanced manufacturing and prototyping capabilities in the United States. The financing would support PsiQuantum's 140,000-square-foot hub in Milpitas, California, for scaling the company's state-of-the-art technologies and developing and validating the prototype systems that underpin its fault-tolerant quantum computing architecture. Combined with co-investment from PsiQuantum, which anchors its supply chain in the United States, this new financing would strengthen the company's domestic capacity for design, testing, and system integration as PsiQuantum advances toward building utility-scale, fault-tolerant quantum computers in the United States. "Today's announcement shows the U.S. government's bold leadership and continued commitment to quantum computing as a critical technology for America's economic prosperity and national security," said Victor Peng, Chief Executive Officer of PsiQuantum. "Delivering on the full promise of this technology in the United States will require world-class manufacturing and engineering ecosystems, and this potential financing underscores the vital role Washington can play." Financing from the Office of Strategic Capital would support PsiQuantum's acquisition of critical infrastructure and equipment required for constructing, testing, and validating prototype quantum systems, including: * Test equipment for the fabrication and validation of components, subassemblies, and system-level assemblies * Critical infrastructure for system assembly, integration, and testing * Advanced cryogenic systems for prototype systems PsiQuantum's potential financing from the Department of Defense would be deployed by the company to expand and strengthen domestic quantum computing capacity. Today's announcement follows a twelve-month period of strong momentum for PsiQuantum as the company continues to develop its quantum infrastructure globally. This June, PsiQuantum broke ground and started construction on its facility at Moreton Bay Central in Queensland, Australia. In September 2025, the company broke ground on its site at the Illinois Quantum and Microelectronics Park in Chicago. The proposed financing remains strictly conditional and is not guaranteed. A final loan commitment will only be executed if PsiQuantum satisfies all applicable financial, legal, technical, and regulatory conditions outlined in the conditional commitment. About PsiQuantum PsiQuantum was founded in 2016 and is headquartered in Palo Alto, California. The company's mission is to build and deploy the world's first useful quantum computers. PsiQuantum's photonic approach enables it to leverage high-volume semiconductor manufacturing, existing cryogenic infrastructure, and architectural flexibility to rapidly scale its systems. Learn more at www.psiquantum.com. For all the talk about a shortage of AI computing power, and the need for... The Department of Energy today unveiled a dozen Phase II awards for its Genesis Mission... DARPA announced today that Atom Computing, Diraq, IBM and IonQ have advanced to the final... The U.S. Department of Energy is launching a competition with up to $215 million in planned... OpenAI says one of its AI systems has solved a math problem that has stumped... Quantum practitioners should stop wondering if quantum computer hardware is ready soon and start worrying...
Future product development in Quantum Chemistry & Quantum Life Sciences & Expected timelines to market. IQT Quantum Chemicals and Quantum Life Science Long-term product development in quantum chemistry and quantum life sciences is shifting from theoretical proofs-of-concept into structural, industrial application. Hardware and software developers are engineering full-stack platforms to bypass the limitations of classical computers for atomic and biological simulations. [1, 2] The primary long-term product initiatives in both fields, along with the key organizations leading them, include the following: * Quantum Chemistry product development. Long-term R&D in quantum chemistry centers on first-principles molecular modeling, industrial catalyst design, and material lifecycle simulations. [1, 2] * Algorithmic and Cloud Software Platforms: Companies are actively coding cloud-based software suites that can map electron behavior with perfect precision. * Quantinuum is scaling its InQuanto(TM) platform for molecular and materials simulation. * QC Ware is developing Promethium(R), a SaaS platform hosted on AWS Marketplace designed to handle complex chemical systems of up to 2,000 atoms. * Microsoft maintains the Azure Quantum Chemistry Library, integrating high-level Q# quantum instructions with legacy classical packages like NWChem. [1] * Zapata Quantum (partnering with NVIDIA) is building agentic AI workflows to automate quantum resource estimation for advanced materials development. [1, 2 * Industrial Catalysts and Process Innovation: * Global chemical giants are financing deep-tech software to redesign fundamental chemical reactio * BASF and Dow Chemical are engineering simulations to map nitrogen fixation and polymer degradation, aiming to shorten catalytic research timelines from several years to mere weeks * Quantum Life Sciences product development. Quantum life science development focuses on multi-objective molecular drug design, complex protein folding, and subatomic biological mechanism simulations. [1]. * End-to-End Computational Drug Discovery Engines: R&D platforms are migrating away from slow, single-property screening toward parallel, multi-objective optimization of massive molecular libraries. * PolarisQB: Developing QUAD (Quantum Aided Drug Design) software running on D-Wave Quantum systems, designed to screen a vast chemical space of \(10^{30}\) molecules within days to evaluate drug activity, solubility, and biodegradability simultaneously. * Qubit Pharmaceuticals: Actively scaling its ATLAS hybrid computing platform, which integrates physics-inspired algorithms to model metalloenzymes and GPCR targets for oncology and pandemic response pipelines. * Algorithmic: Collaborating with IBM to build fault-tolerant quantum algorithms specifically aimed at cutting down pre-clinical pharmaceutical timelines. [1, 2, 3] * Biopharma Pipeline Integrations * Multi-national pharmaceutical brands are embedding quantum workflows into their existing pipelines to model disease targets. * Boehringer Ingelheim: Working with Google Quantum AI to model electronic structures of complex proteins, and with PsiQuantum to simulate metalloenzyme dynamics. * Moderna: Utilizing IBM Quantum systems to run high-dimensional mRNA secondary structure simulations to engineer ultra-stable mRNA therapies. * AstraZeneca: Partnered with IonQ, NVIDIA, and AWS to finalize quantum-accelerated workflows targeting small-molecule synthesis. * Amgen and GlaxoSmithKline: Developing quantum machine learning platforms with Quantinuum to classify peptide binding vectors and automate automated fragment-linking. [1, 2, 3]. Cross-Market Comparison | Field | Primary Long-Term Objective | Key Developer Archetypes | Prominent Commercial Software Platforms | | Quantum Chemistry | Catalyst design, nitrogen fixation, polymer degradation, battery chemistry. Industrial chemical firms, hyperscalers, full-stack quantum providers. InQuanto (Quantinuum), Promethium (QC Ware), Azure Quantum (Microsoft). | | Quantum Life Sciences | Multi-objective lead optimization, mRNA modeling, targeted oncology therapies. Biopharma giants, biotech pure-plays, quantum hardware-software labs. QUAD (PolarisQB), ATLAS (Qubit Pharmaceuticals), Qiskit Runtime (IBM). | Expected Timelines and Specific Products for each sector include: * Quantum Chemistry products (timeline: 2028-2030). Because industrial chemical products face faster development-to-market loops than human pharmaceuticals, chemistry will be the first sector to yield tangible, on-the-shelf items. [1, 2] * Solid-State Electric Vehicle Batteries: Quantum-classical hybrid pipelines are already screening tens of millions of potential materials to isolate optimal solid-state battery electrolytes. Early results include new material variations that use up to 70% less lithium while maintaining high conductivity. Consumer electronics and automotive batteries utilizing these quantum-discovered materials are slated for production near 2028-2029. [1, 2] * Ultra-Durable Coatings & Anti-Corrosives: Major aerospace and energy firms are leveraging early quantum systems to simulate metal corrosion and molecular stress. Consumers will see the results in ultra-hard carbon phases (up to 30% more compressively resistant than diamond) used in industrial tools, consumer electronics casing, and highly durable automotive coatings. [1, 2] * Next-Generation Crop Fertilizers: Chemical giants like BASF are using near-term quantum simulators to model the nitrogenase enzyme. This research aims to replicate natural nitrogen fixation, replacing energy-intensive industrial fertilizer processes with sustainable, quantum-optimized agricultural products by 2030. [1, 2] * Quantum Life Science products (timeline: 2035+). The timeline for life sciences is significantly extended because of human safety trials. Even if a quantum computer perfectly simulates a therapeutic molecule today, that drug must still undergo 10 to 12 years of clinical trials before it can be purchased at a pharmacy. [1] * Targeted Oncology & Cancer Therapies: Current hybrid pipelines utilize quantum machine learning models to narrow down millions of molecular configurations into high-success candidates for complex cancer targets. The resulting highly targeted, low-side-effect small molecule drugs are moving into early development pipelines now, targeting regulatory approval in the mid-2030s. [1, 2, 3, 4] * Quantum-Optimized mRNA Vaccines: Biotech innovators like Moderna are leveraging quantum-enhanced modeling to design stable mRNA sequences. These formulations optimize how a vaccine interacts with human drug metabolism enzymes at a atomic level, leading to faster-acting booster formulations and highly personalized vaccines. [1, 2] * Precision Neurological Drugs: Simulating how large biological macromolecules fold is incredibly difficult for classical computers. Fault-tolerant quantum computing systems, expected to mature in the early 2030s, will allow the simulation of large proteins (exceeding 12,000 atoms). This will yield highly precise treatments for complex neurological diseases like Alzheimer's, arriving on the shelves in the late 2030s. [1, 2, 3, 4] | Industry Sector | Expected Shelf Date | Primary Consumer/Industrial Products | | Quantum Chemistry | 2028 - 2030 | Low-lithium solid-state EV batteries, diamond-hard protective coatings, eco-friendly fertilizers. | | Quantum Life Sciences | 2035 and beyond | Targeted small-molecule cancer drugs, rapid-response mRNA therapeutics, precision neurological treatments. |
Rockford Brake Manufacturing receives state honor for local impact. ROCKFORD - A historic manufacturer that was revived after bankruptcy was honored Thursday night with one of the inaugural Illinois Impact awards by the Illinois Economic Development Corporation. Rockford Brake Manufacturing, 302 Peoples Ave., was one of four companies to receive the Governor's Award for Local Impact, which recognizes businesses whose investment, growth and long-term presence strengthens the community and regional economy. There were also awards given for Innovator of the Year (Rivian), Large Development of the Year (Hyundai Translead) and Team Illinois Partner of the Year (IQMP, Related Midwest, Clayco, and PsiQuantum). The awards were bestowed to Rockford Brake and other companies at the Obama Presidential Center in Chicago. Rockford Brake, which was purchased out of Chapter 11 bankruptcy a year ago by four former Gunite employees, has now provided $20 million in direct economic impact, including more than $7 million in wages and benefits to its 130-plus employees, according to the company. "Rockford Brake is thrilled to receive the Governor's Award for Local Impact - Northern Illinois. Rockford Brake's success is due to the people we have been able to bring into the organization. The strong generational foundation of manufacturing talent in northern Illinois has meant we have been able to ramp up production with skilled team members to support the rapid growth of the company," Paul Wright, CEO of Rockford Brake, said in a news release. "The investment Illinois continues to make in manufacturing provides the platform for companies like ours to compete and win." Rockford Brake won the governor's award for northern Illinois. It went to ADM and Rural King in central Illinois and Continental Tire in southern Illinois. "The Illinois Impact Awards celebrate the very best of Team Illinois - the people and organizations working together to attract investment, drive innovation, create good-paying jobs, and strengthen communities across our state," Gov. JB Pritzker said in a news release. "From advanced manufacturing to clean energy to quantum and other emerging technologies, our honorees reflect the hard work and bold vision that is driving our state's historic economic progress. I'm honored to recognize their leadership and look forward to building on our efforts to make Illinois the best place to live, work, and do business." Rockford Brake restarted work about a year ago. The revival came about 11 months after Accuride, the former parent company of Gunite, closed the factory while it restructured under Chapter 11 bankruptcy. The closure led to 327 layoffs and left the site idle. The plant was then purchased by four former employees: Brandon Baumann, Mike Brandi Jr., Tim Davis and Scott Henderson. The factory, through several ownership changes, has been in business in Rockford since 1854.
PsiQuantum has secured $450 million in funding from investors including Sequoia Capital and BlackRock. The quantum computing startup will use the funds to develop its superconducting qubit technology and high-fidelity readout system as it works towards building a functional quantum computer. The investment round was led by Sequoia Capital and BlackRock, with participation from strategic partners in the technology and defence sectors. The funding will enable PsiQuantum to scale up operations and accelerate bringing its quantum computing solutions to market.